Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Nephrotoxicity

Nephrotoxicity

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Nephrotoxicity

3 trials tracked for Nephrotoxicity: 1 in phase 3 or 4.

3Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 2 1 Other / NA 1
  1. Phase 4 Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients Completed
  2. Phase 2 Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy Completed
  3. N/A Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Model-informed precision dosing improves vancomycin target attainment in critically ill children compared to standard therapeutic drug monitoring
Infectious Disease RCT
Model-informed precision dosing improves vancomycin target attainment in critically ill children compared to standard therapeutic drug monitoring New dosing model helps severely ill children hit drug targets faster
In critically ill children, model-informed precision dosing significantly improved vancomycin target attainment versus standard monitoring. …
A new dosing method helped more critically ill children reach the right drug levels in their blood within two days of starting treatment for…
Jun 1, 2026